Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Pfizer Limited market capitalisation for the company's overall valuation and market capitalisation.
Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Pfizer Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency. Explore PFIZER operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WK Kellogg Co
NYSE:KLG
|
0.072x |
|
Dno ASA
OL:DNO
|
0.225x |
|
Resolute Mining Ltd
AU:RSG
|
0.174x |
|
RLX TECH. SP.ADR/1 CL.A
F:3CM
|
0.020x |
|
Kangwon Land
KO:035250
|
0.030x |
|
Cimpress NV
NASDAQ:CMPR
|
-0.277x |
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
0.022x |
|
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO
|
-0.224x |
Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. View PFIZER stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs42.03 Billion ≈ $454.53 Million |
Rs11.44 Billion ≈ $123.67 Million |
0.272x | +73.94% |
| 2025-03-31 | Rs42.17 Billion ≈ $456.10 Million |
Rs6.60 Billion ≈ $71.35 Million |
0.156x | +119.00% |
| 2024-03-31 | Rs35.96 Billion ≈ $388.84 Million |
Rs2.57 Billion ≈ $27.78 Million |
0.071x | -35.59% |
| 2023-03-31 | Rs32.07 Billion ≈ $346.86 Million |
Rs3.56 Billion ≈ $38.47 Million |
0.111x | -52.38% |
| 2022-03-31 | Rs28.64 Billion ≈ $309.78 Million |
Rs6.67 Billion ≈ $72.14 Million |
0.233x | +30.42% |
| 2021-03-31 | Rs23.93 Billion ≈ $258.80 Million |
Rs4.27 Billion ≈ $46.21 Million |
0.179x | +87.62% |
| 2020-03-31 | Rs33.95 Billion ≈ $367.21 Million |
Rs3.23 Billion ≈ $34.95 Million |
0.095x | +193.03% |
| 2019-03-31 | Rs30.11 Billion ≈ $325.66 Million |
Rs978.10 Million ≈ $10.58 Million |
0.032x | -73.73% |
| 2018-03-31 | Rs26.83 Billion ≈ $290.18 Million |
Rs3.32 Billion ≈ $35.88 Million |
0.124x | -9.03% |
| 2017-03-31 | Rs24.19 Billion ≈ $261.59 Million |
Rs3.29 Billion ≈ $35.56 Million |
0.136x | -16.22% |
| 2016-03-31 | Rs21.18 Billion ≈ $229.05 Million |
Rs3.44 Billion ≈ $37.16 Million |
0.162x | +182.10% |
| 2015-03-31 | Rs19.73 Billion ≈ $213.37 Million |
Rs1.13 Billion ≈ $12.27 Million |
0.058x | -71.41% |
| 2014-03-31 | Rs6.58 Billion ≈ $71.20 Million |
Rs1.32 Billion ≈ $14.32 Million |
0.201x | +4060.27% |
| 2013-03-31 | Rs16.94 Billion ≈ $183.25 Million |
Rs-86.07 Million ≈ $-930.79K |
-0.005x | -127.10% |
| 2012-03-31 | Rs13.05 Billion ≈ $141.10 Million |
Rs244.59 Million ≈ $2.65 Million |
0.019x | -86.64% |
| 2011-03-31 | Rs11.63 Billion ≈ $125.82 Million |
Rs1.63 Billion ≈ $17.66 Million |
0.140x | +86.88% |
| 2010-03-31 | Rs9.94 Billion ≈ $107.53 Million |
Rs746.73 Million ≈ $8.08 Million |
0.075x | -71.54% |
| 2009-03-31 | Rs9.01 Billion ≈ $97.45 Million |
Rs2.38 Billion ≈ $25.71 Million |
0.264x | +941.98% |
| 2008-03-31 | Rs6.50 Billion ≈ $70.26 Million |
Rs164.53 Million ≈ $1.78 Million |
0.025x | -90.96% |
| 2007-03-31 | Rs4.40 Billion ≈ $47.56 Million |
Rs1.23 Billion ≈ $13.32 Million |
0.280x | +2.51% |
| 2006-03-31 | Rs3.76 Billion ≈ $40.66 Million |
Rs1.03 Billion ≈ $11.11 Million |
0.273x | +6.40% |
| 2005-03-31 | Rs3.40 Billion ≈ $36.72 Million |
Rs872.08 Million ≈ $9.43 Million |
0.257x | -- |
About Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterolog… Read more